Related Experiment Video
Updated: Jun 2, 2026

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Lipidomics reveals the serum profiles of pediatric allergic rhinitis and its severity
Tao Li1,2, Yuzhu Dou1,2, Jianjian Ji2
1Department of Pediatrics, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Insights
This study reveals distinct serum lipid profiles in children with allergic rhinitis (AR), identifying specific fatty acids and glycerolipids linked to AR and its severity. These findings offer new insights into AR
Area of Science:
- Biochemistry
- Immunology
- Pediatrics
Background:
- Allergic rhinitis (AR) is a widespread chronic inflammatory condition affecting children globally.
- While bioactive lipids are known to influence AR, the specific serum lipidomic alterations in pediatric AR remain largely uncharacterized.
Purpose of the Study:
- To investigate the serum lipidomic profiles of children diagnosed with allergic rhinitis.
- To identify specific lipids associated with AR and explore their diagnostic potential and correlation with disease severity markers.
Main Methods:
- Employed ultra-performance liquid chromatography coupled with Q-Exactive Orbitrap mass spectrometry (UPLC-Q-Exactive Orbitrap/MS) for serum lipidomic analysis.
- Compared lipid profiles between children with AR (n=75) and healthy controls (n=44).
- Utilized receiver operating characteristic (ROC) curve analysis to assess the diagnostic value of identified lipids.
Main Results:
- Identified 42 differentially expressed lipids between AR patients and controls (p < 0.05, fold change > 2).
- Significantly elevated serum levels of diacylglycerols (DG), triacylglycerols (TG), fatty acids (FA), lysophosphatidylcholines (LPC), and other lipids were observed in the AR group.
- Five lipids (FA 30:7, LPC O-18:1, LPC 18:0, LPC 16:0, DG 34:0) demonstrated high diagnostic potential (Area Under Curve > 0.9).
- Positive correlations were found between serum IgE and IL-33 levels and serum DGs, LPCs, TGs, and FAs in AR patients.
Conclusions:
- This research elucidates the specific lipidomic alterations associated with allergic rhinitis in children.
- The identified lipids, particularly DG, TG, FA, and LPCs, are implicated in AR pathology and severity.
- These findings provide novel insights into the role of lipid metabolism in pediatric AR and suggest potential biomarkers for diagnosis and severity assessment.
Abstract:
Allergic rhinitis (AR) is a prevalent upper airway chronic inflammatory disease in children worldwide. The role of bioactive lipids in the regulation of AR has been recognized, but the underlying serum lipidomic basis of its pathology remains unclear. We utilized ultra-performance liquid chromatography (UPLC)-Q-Exactive Orbitrap/mass spectrometry (MS) to investigate the serum lipidomic profiles of children with AR. The lipidomic analysis identified 42 lipids that were differentially expressed (p < 0.05, fold change > 2) between the AR (n = 75) and normal control groups (n = 44). Specifically, the serum levels of diacylglycerol (DG), triacylglycerol (TG), fatty acid (FA), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine, phosphatidyl-ethanolamine, and cardiolipins were significantly higher in the AR group. The diagnostic potential of the identified lipids was further evaluated using receiver operating characteristic curve analysis. The analysis revealed that five lipids, including FA 30:7, LPC O-18:1, LPC 18:0, LPC 16:0, and DG 34:0, had area under the curve values greater than 0.9 (p < 0.05). Furthermore, serum levels of IgE and IL-33, markers of AR severity, were found to have a significant positive correlation (p < 0.05) with DGs, LPCs, TGs, and FAs in AR patients. This study revealed the lipid disorders associated with AR and its severity, providing new insights into the pathological process of AR.
More Related Videos
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Pneumonia III: Complications and Assessment

